Market revenue in 2023 | USD 161.8 million |
Market revenue in 2030 | USD 445.9 million |
Growth rate | 15.6% (CAGR from 2023 to 2030) |
Largest segment | Spinal cord stimulator |
Fastest growing segment | Sacral Nerve Stimulator |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Spinal Cord Stimulator, Deep Brain Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator, Gastric Electric Stimulator |
Key market players worldwide | Medtronic PLC, LivaNova PLC, Boston Scientific Corp, St. Jude Medical, Nevro Corp |
Spinal cord stimulator was the largest segment with a revenue share of 49.13% in 2023. Horizon Databook has segmented the Japan neurostimulation devices market based on spinal cord stimulator, deep brain stimulator, sacral nerve stimulator, vagus nerve stimulator, gastric electric stimulator covering the revenue growth of each sub-segment from 2018 to 2030.
As per Statistics Bureau of Japan, in 2017, 27.7% of the total population is 65 years or above, which is expected to increase to 31.2% in 2030. In 2014, Japan’s suicide rate was 19.5 as compared to other countries such as 12.6 in Germany and 7.5 in Britain. Thus, factors such as introduction of technological advancements, increasing geriatric population, and growing demand of neuromodulation as an add-on therapy are expected to drive the market.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account